Prognostic factors for short-term survival in patients with stage IV non-small cell lung cancer

Japanese Journal of Cancer Research

Volumn 90, Issue 2, 1999, Pages 249-253

  Ando, Masahiko ^a,b   Ando, Yuichi ^b   Sugiura, Seiji ^b   Minami, Hironobu ^c   Saka, Hideo ^b   Sakai, Shuzo ^a   Shimokata, Kaoru ^b   Hasegawa, Yoshinori ^b  

^a JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

Metastasis; Minimum life expectancy; Non small cell lung cancer; Performance status

Indexed keywords

LACTATE DEHYDROGENASE;

AGED; ARTICLE; BONE METASTASIS; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; LIFE EXPECTANCY; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MODEL; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; WEIGHT REDUCTION;

EID: 0032991503     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1999.tb00740.x     Document Type: Article

References (12)

1. Mountain, C. F. Revisions in the international system for staging lung cancer. Chest, 111, 1710-1717 (1997).
2. O'Connell, J. P., Kris, M. G., Gralla, R. J., Groshen, S., Trust, A., Fiore, J. J., Kelsen, D. P., Heelan, R. T. and Golbey, R. B. Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy. J. Clin. Oncol., 4, 1604-1614 (1986).
3. Sørensen, J. B., Badsberg, J. H. and Olsen, J. Prognostic-factors in inoperable adenocarcinoma of the lung: a multivariate regression analysis of 259 patients. Cancer Res., 49, 5748-5754 (1989).
4. Albain, K. S., Crowley, J. J., LeBlanc, M. and Livingston, R. B. Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience. J. Clin. Oncol., 9, 1618-1626 (1991).
5. Shinkai, T., Eguchi, K., Sasaki, Y., Tamura, T., Ohe, Y., Kojima, A., Oshita, F., Miya, T., Okamoto, H., Iemura, K. and Saijo, N. A prognostic-factor risk index in advanced non-small-cell lung cancer treated with cisplatin-containing combination chemotherapy. Cancer Chemother. Pharmacol., 30, 1-6 (1992).
6. Finkelstein, D. M., Ettinger, D. S. and Ruckdeschel, J. C. Long-term survivors in metaslatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study. J. Clin. Oncol., 4, 702-709 (1986).
7. Paesmans, M., Sculier, J. P., Libert, P., Bureau, G., Dabouis, G., Thiriaux, J., Michel, J., Van Cutsem, O., Sergysels, R., Mommen, P. and Klastersky, J. Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party. J. Clin. Oncol., 13, 1221-1230 (1995).
8. Leventhal, B. G. and Wittes, R. E. Phase I trials. In "Research Methods in Clinical Oncology," pp. 41-59 (1988). Raven Press, New York.
9. Evans, C. and McCarthy, M. Prognostic uncertainty in terminal care: can the Karnofsky index help? Lancet, 1, 1204-1206 (1985).
10. Ihde, D. C. Chemotherapy of lung cancer. N. Engl. J. Med., 327, 1434-1441 (1992).
11. Shepherd, F. A. Treatment of advanced non-small cell lung cancer. Semin. Oncol., 21, 7-18 (1994).
12. Ruckdeschel, J. C., Finkelstein, D. M., Ettinger, D. S., Creech, R. H., Mason, B. A. and Vogl, S. A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer. J. Clin. Oncol., 4, 14-22 (1986).